Longeveron stock jumps on Alzheimer’s trial results By: MarketWatch October 05, 2023 at 08:13 AM EDT Treatment derived from bone marrow shows promise in patients with mild Alzheimer's disease. Read More >> Related Stocks: Longeveron Inc